FTII FutureTech II Acquisition Corp.

Biological Products, (No Diagnostic Substances) CIK: 0001889450
AI RATING
STRONG_SELL
95% Confidence

Investment Thesis

FutureTech II is a financially distressed acquisition company with negative stockholders' equity of -9.6M, indicating the company is technically insolvent. Severe liquidity constraints (current ratio of 0.21x) combined with negative operating cash flow of -1.2M and a cash position of only 160.7K creates an existential crisis. The company is burning cash rapidly with no revenue generation and mounting losses, making it unsuitable for equity investment.

Strengths

  • + Company has not yet filed for bankruptcy or ceased operations
  • + Minimal insider selling pressure in last 90 days suggests no forced liquidations
  • + May have acquisition or reverse merger potential as a shell entity

Risks

  • ! Negative stockholders' equity of -9.6M indicates technical insolvency and shareholder claims are fully subordinated to creditors
  • ! Critical liquidity crisis: current ratio of 0.21x with only 160.7K cash against 10.4M liabilities threatens immediate solvency
  • ! Severe cash burn: negative operating cash flow of -1.2M annually with no revenue means remaining cash runway is less than 2 months
  • ! No revenue generation capability documented; operating losses of -320.3K indicate ongoing operations without income
  • ! Interest coverage ratio of -3.2x shows inability to service debt obligations
  • ! ROA of -3.5% confirms systematic destruction of asset value

Key Metrics to Watch

Financial Metrics

Revenue
N/A
Net Income
-370.3K
EPS (Diluted)
$0.00
Free Cash Flow
-1.2M
Total Assets
10.6M
Cash
160.7K

Profitability Ratios

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
ROE N/A
ROA -3.5%
FCF Margin N/A

Balance Sheet & Liquidity

Current Ratio
0.21x
Quick Ratio
0.21x
Debt/Equity
N/A
Debt/Assets
98.1%
Interest Coverage
-3.20x
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-03-25T09:18:11.978174 | Data as of: 2025-06-30 | Powered by Claude AI